First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Clinical trial NCT04880291 · COMPLETED

Trial details

NCT number: NCT04880291
Sponsor: Goldfinch Bio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Diseases Diabetic Nephropathies Diabetes Complications Diabetes Mellitus Endocrine System Diseases

Start date: 2021-05-05
Primary completion: 2022-02-08
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.